Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/13181| Title: | The use of novel anticoagulants in non-valvular atrial fibrillation |
| Authors: | Cassar, Andrew |
| Keywords: | Atrial fibrillation Cerebrovascular disease Anticoagulants (Medicine) |
| Issue Date: | 2013 |
| Publisher: | Medical Portals Ltd. |
| Citation: | Cassar, A. (2013). The use of novel anticoagulants in non-valvular atrial fibrillation. The Synapse, (3), 16,18 |
| Abstract: | Atrial Fibrillation (AF) occurs in 1-2% of the general population, making it the commonest sustained cardiac arrhythmia. It becomes more common as one gets older, with a prevalence of 5-15% at 80 years of age. Atrial fibrillation is independently associated with doubling of mortality, mostly associated with a higher risk of stroke. One-fifth of strokes are due to AF, with a proportion of 'cryptogenic' also likely to have undiagnosed AF as a cause. Anti-thrombotic therapy is the only treatment which reduces deaths in patients with AF. |
| URI: | https://www.um.edu.mt/library/oar//handle/123456789/13181 |
| Appears in Collections: | Scholarly Works - FacM&SMed The Synapse, Issue 3 The Synapse, Issue 3 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| The use of novel anticoagulants.pdf | 688.05 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.